IDEAYA Biosciences, Inc.
NASDAQ:IDYA
Overview | Financials
Company Name | IDEAYA Biosciences, Inc. |
Symbol | IDYA |
Currency | USD |
Price | 25.61 |
Market Cap | 2,213,518,398 |
Dividend Yield | 0% |
52-week-range | 24.475 - 47.735 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Yujiro S. Hata |
Website | https://www.ideayabio.com |
An error occurred while fetching data.
About IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD